Logo Image
Opinion|Videos|April 4, 2025

Comparing Standard-of-Care Antibiotics for Uncomplicated UTIs

Panelists discuss how standard-of-care antibiotics for uncomplicated urinary tract infections (UTIs) show varying efficacy, with nitrofurantoin and fosfomycin demonstrating superior response rates (85%-95%) compared with trimethoprim/sulfamethoxazole (70%-80% due to increasing resistance) and first-generation cephalosporins (80%-90%), and how cost-effectiveness depends on local resistance patterns, patient adherence to dosing schedules, medication costs and insurance coverage, treatment duration, recurrence rates, comorbidities, and potential adverse effects requiring additional interventions.

Episodes in this series

Video content above is prompted by the following:

  • How do current standard-of-care antibiotics such as nitrofurantoin, trimethoprim/sulfamethoxazole, fosfomycin, and first-generation cephalosporins compare in terms of patient response rates for uncomplicated UTIs?
  • What factors may contribute to one drug being more cost-effective than another in specific patient populations?

Related Content